| Literature DB >> 29791458 |
Mindy C DeRouen1,2,3, Lauren Hu4, Meg McKinley1,3, Kathleen Gali5, Manali Patel6,7,8,9, Christina Clarke1,9, Heather Wakelee6,9, Robert Haile10, Scarlett Lin Gomez1,2,3,11, Iona Cheng1,2,3,11.
Abstract
BACKGROUND: The relationships between neighborhood factors (i.e., neighborhood socioeconomic status (nSES) and ethnic enclave) and histologic subtypes of lung cancer for racial/ethnic groups, particularly Hispanics and Asian American/Pacific Islanders (AAPIs), are poorly understood.Entities:
Mesh:
Year: 2018 PMID: 29791458 PMCID: PMC5965814 DOI: 10.1371/journal.pone.0197146
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Distribution of neighborhood factors and clinical characteristics according to race/ethnicity among lung cancer cases, California 2008–2012.
| Race/ethnicity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total | Hispanic | AAPI | Black | White | ||||||
| Male | Female | Male | Female | Male | Female | Male | Female | Male | Female | |
| N = 39,457 | N = 36,174 | N = 4406 | N = 3889 | N = 4915 | N = 3634 | N = 3258 | N = 2704 | N = 26,878 | N = 25,947 | |
| n | n | n | n | n | n | n | n | n | n | |
| (%) | (%) | (%) | (%) | (%) | (%) | (%) | (%) | (%) | (%) | |
| Q4-high | 9546 | 9639 | 459 | 528 | 1373 | 1177 | 334 | 254 | 7380 | 7680 |
| (24.2%) | (26.6%) | (10.4%) | (13.6%) | (27.9%) | (32.4%) | (10.3%) | (9.4%) | (27.5%) | (29.6%) | |
| Q3 | 10710 | 10056 | 863 | 878 | 1410 | 1008 | 665 | 526 | 7772 | 7644 |
| (27.1%) | (27.8%) | (19.6%) | (22.6%) | (28.7%) | (27.7%) | (20.4%) | (19.5%) | (28.9%) | (29.5%) | |
| Q2 | 10843 | 9488 | 1283 | 1086 | 1290 | 878 | 910 | 807 | 7360 | 6717 |
| (27.5%) | (26.2%) | (29.1%) | (27.9%) | (26.2%) | (24.2%) | (27.9%) | (29.8%) | (27.4%) | (25.9%) | |
| Q1-low | 8358 | 6991 | 1801 | 1397 | 842 | 571 | 1349 | 1117 | 4366 | 3906 |
| (21.2%) | (19.3%) | (40.9%) | (35.9%) | (17.1%) | (15.7%) | (41.4%) | (41.3%) | (16.2%) | (15.1%) | |
| Q1-low | ~ | ~ | 452 | 503 | 202 | 197 | ~ | ~ | ~ | ~ |
| (10.3%) | (12.9%) | (4.1%) | (5.4%) | |||||||
| Q2 | ~ | ~ | 744 | 805 | 511 | 454 | ~ | ~ | ~ | ~ |
| (16.9%) | (20.7%) | (10.4%) | (12.5%) | |||||||
| Q3 | ~ | ~ | 1257 | 1141 | 965 | 737 | ~ | ~ | ~ | ~ |
| (28.5%) | (29.3%) | (19.6%) | (20.3%) | |||||||
| Q4- high | ~ | ~ | 1953 | 1440 | 3237 | 2246 | ~ | ~ | ~ | ~ |
| (44.3%) | (37.0%) | (65.9%) | (61.8%) | |||||||
| Adenocarcinoma | 17126 | 18803 | 1897 | 2084 | 2584 | 2610 | 1386 | 1317 | 11259 | 12792 |
| (43.4%) | (52.0%) | (43.1%) | (53.6%) | (52.6%) | (71.8%) | (42.5%) | (48.7%) | (41.9%) | (49.3%) | |
| SCC | 9197 | 5617 | 982 | 544 | 920 | 290 | 769 | 475 | 6526 | 4308 |
| (23.3%) | (15.5%) | (22.3%) | (14.0%) | (18.7%) | (8.0%) | (23.6%) | (17.6%) | (24.3%) | (16.6%) | |
| SCLC | 4243 | 4102 | 472 | 406 | 412 | 148 | 282 | 296 | 3077 | 3252 |
| (10.8%) | (11.3%) | (10.7%) | (10.4%) | (8.4%) | (4.1%) | (8.7%) | (10.9%) | (11.4%) | (12.5%) | |
| LC+OSC | 2781 | 2798 | 374 | 364 | 268 | 175 | 219 | 209 | 1920 | 2050 |
| (7.0%) | (7.7%) | (8.5%) | (9.4%) | (5.5%) | (4.8%) | (6.7%) | (7.7%) | (7.1%) | (7.9%) | |
| Unspecified | 6109 | 4854 | 681 | 491 | 730 | 411 | 602 | 407 | 4096 | 3545 |
| (15.5%) | (13.4%) | (15.5%) | (12.6%) | (14.9%) | (11.3%) | (18.5%) | (15.1%) | (15.2%) | (13.7%) | |
| < 50 | 1371 | 1475 | 274 | 308 | 244 | 264 | 131 | 198 | 722 | 705 |
| (3.5%) | (4.1%) | (6.2%) | (7.9%) | (5.0%) | (7.3%) | (4.0%) | (7.3%) | (2.7%) | (2.7%) | |
| 50–59 | 5350 | 4753 | 610 | 602 | 679 | 601 | 717 | 557 | 3344 | 2993 |
| (13.6%) | (13.1%) | (13.8%) | (15.5%) | (13.8%) | (16.5%) | (22.0%) | (20.6%) | (12.4%) | (11.5%) | |
| 60–69 | 11456 | 9968 | 1181 | 1050 | 1348 | 920 | 1055 | 842 | 7872 | 7156 |
| (29.0%) | (27.6%) | (26.8%) | (27.0%) | (27.4%) | (25.3%) | (32.4%) | (31.1%) | (29.3%) | (27.6%) | |
| 70–79 | 13092 | 11967 | 1449 | 1206 | 1593 | 1136 | 968 | 761 | 9082 | 8864 |
| (33.2%) | (33.1%) | (32.9%) | (31.0%) | (32.4%) | (31.3%) | (29.7%) | (28.1%) | (33.8%) | (34.2%) | |
| 80+ | 8188 | 8011 | 892 | 723 | 1051 | 713 | 387 | 346 | 5858 | 6229 |
| (20.8%) | (22.1%) | (20.2%) | (18.6%) | (21.4%) | (19.6%) | (11.9%) | (12.8%) | (21.8%) | (24.0%) | |
| Localized | 6602 | 7634 | 552 | 795 | 706 | 672 | 461 | 455 | 4883 | 5712 |
| (16.7%) | (21.1%) | (12.5%) | (20.4%) | (14.4%) | (18.5%) | (14.1%) | (16.8%) | (18.2%) | (22.0%) | |
| Regional | 8594 | 7870 | 886 | 789 | 993 | 701 | 709 | 607 | 6006 | 5773 |
| (21.8%) | (21.8%) | (20.1%) | (20.3%) | (20.2%) | (19.3%) | (21.8%) | (22.4%) | (22.3%) | (22.2%) | |
| Distant | 23121 | 19540 | 2815 | 2169 | 3043 | 2143 | 1995 | 1566 | 15268 | 13662 |
| (58.6%) | (54.0%) | (63.9%) | (55.8%) | (61.9%) | (59.0%) | (61.2%) | (57.9%) | (56.8%) | (52.7%) | |
| Unstaged | 1096 | 1068 | 149 | 127 | 166 | 111 | 92 | 74 | 689 | 756 |
| (2.8%) | (3.0%) | (3.4%) | (3.3%) | (3.4%) | (3.1%) | (2.8%) | (2.7%) | (2.6%) | (2.9%) | |
1. The ethnic enclave variable is defined only for Hispanic and Asian race/ethnicities.
2. AAPI, Asian American/Pacific Islander; nSES, neighborhood socioeconomic status; IRR, incidence rate ratio; CI, confidence interval; SCC, squamous cell carcinoma; SCLC, small cell lung cancer; LC+OSC, large cell and other cell lung cancer
Lung cancer incidence rate ratios for all lung cancers and histologic cell-types by nSES for males according to race/ethnicity, California 2008–2012.
| Hispanic | AAPI | Black | White | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nSES | Cases | IRR | (95% CI | Cases | IRR | (95% CI) | Cases | IRR | (95% CI) | Cases | IRR | (95% CI) | |
| Overall lung cancer | Q4-high | 459 | 1.00 | reference | 1373 | 1.00 | reference | 334 | 1.00 | reference | 7380 | 1.00 | reference |
| Q3 | 863 | 1.01 | (0.90, 1.14) | 1410 | 665 | 7772 | |||||||
| Q2 | 1283 | 1.00 | (0.89, 1.12) | 1290 | 910 | 7360 | |||||||
| Q1-low | 1801 | 1.02 | (0.92, 1.14) | 842 | 1349 | 4366 | |||||||
| Adenocarcinoma | Q4-high | 224 | 1.00 | reference | 803 | 1.00 | reference | 165 | 1.00 | reference | 3584 | 1.00 | reference |
| Q3 | 367 | 0.88 | (0.74, 1.05) | 747 | 1.08 | (0.98, 1.20) | 284 | 0.95 | (0.77, 1.17) | 3288 | |||
| Q2 | 556 | 0.87 | (0.74, 1.02) | 643 | 1.09 | (0.98, 1.21) | 393 | 1.03 | (0.85, 1.26) | 2869 | |||
| Q1-low | 750 | 0.86 | (0.74, 1.01) | 391 | 1.07 | (0.94, 1.21) | 544 | 1.18 | (0.98, 1.43) | 1518 | |||
| SCC | Q4-high | 95 | 1.00 | reference | 223 | 1.00 | reference | 67 | 1.00 | reference | 1508 | 1.00 | reference |
| Q3 | 207 | 1.20 | (0.93, 1.57) | 252 | 160 | 1854 | |||||||
| Q2 | 289 | 1.16 | (0.91, 1.50) | 260 | 215 | 1918 | |||||||
| Q1-low | 391 | 1.12 | (0.88, 1.43) | 185 | 327 | 1246 | |||||||
| SCLC | Q4-high | 41 | 1.00 | reference | 88 | 1.00 | reference | 31 | 1.00 | reference | 706 | 1.00 | reference |
| Q3 | 88 | 1.12 | (0.76, 1.70) | 123 | 57 | 1.03 | (0.63, 1.72) | 912 | |||||
| Q2 | 130 | 1.12 | (0.77, 1.66) | 129 | 78 | 1.19 | (0.76, 1.95) | 902 | |||||
| Q1-low | 213 | 1.35 | (0.95, 1.97) | 72 | 116 | 1.34 | (0.87, 2.14) | 557 | |||||
| LC+OSC | Q4-high | 34 | 1.00 | reference | 69 | 1.00 | reference | 20 | 1.00 | reference | 558 | 1.00 | reference |
| Q3 | 75 | 1.19 | (0.78, 1.88) | 73 | 1.31 | (0.92, 1.87) | 47 | 1.43 | (0.80, 2.64) | 546 | |||
| Q2 | 110 | 1.07 | (0.71, 1.65) | 77 | 64 | 1.43 | (0.83, 2.59) | 506 | |||||
| Q1-low | 155 | 1.11 | (0.76, 1.70) | 49 | 88 | 310 | |||||||
| Unspecified | Q4-high | 65 | 1.00 | reference | 189 | 1.00 | reference | 51 | 1.00 | reference | 1024 | 1.00 | reference |
| Q3 | 126 | 1.01 | (0.73, 1.40) | 215 | 117 | 1.38 | (0.96, 2.03) | 1172 | |||||
| Q2 | 198 | 1.11 | (0.83, 1.52) | 181 | 1.20 | (0.97, 1.48) | 160 | 1165 | |||||
| Q1-low | 292 | 1.16 | (0.88, 1.57) | 145 | 274 | 735 | |||||||
1. Bold type indicates statistical significance
2. AAPI, Asian American/Pacific Islander; nSES, neighborhood socioeconomic status; IRR, incidence rate ratio; CI, confidence interval; SCC, squamous cell carcinoma; SCLC, small cell lung cancer; LC+OSC, large cell and other cell lung cancer
Lung cancer incidence rate ratios for all lung cancers and histologic cell-types by nSES for females according to race/ethnicity, California 2008–2012.
| Hispanic | AAPI | Black | White | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nSES | Cases | IRR | (95% CI | Cases | IRR | (95% CI) | Cases | IRR | (95% CI) | Cases | IRR | (95% CI) | |
| Overall lung cancer | Q4-high | 528 | 1.00 | reference | 1,177 | 1.00 | reference | 254 | 1.00 | reference | 7,680 | 1.00 | reference |
| Q3 | 878 | 0.95 | (0.85, 1.06) | 1,008 | 0.97 | (0.89, 1.06) | 526 | 1.09 | (0.93, 1.27) | 7,644 | |||
| Q2 | 1,086 | 878 | 1.00 | (0.91, 1.09) | 807 | 6,717 | |||||||
| Q1-low | 1,397 | 571 | 1.09 | (0.98, 1.21) | 1,117 | 3,906 | |||||||
| Adenocarcinoma | Q4-high | 320 | 1.00 | reference | 885 | 1.00 | reference | 148 | 1.00 | reference | 4,312 | 1.00 | Reference |
| Q3 | 487 | 0.87 | (0.75, 1.00) | 713 | 0.92 | (0.83, 1.01) | 268 | 0.94 | (0.76, 1.17) | 3,771 | 1.04 | (0.99, 1.08) | |
| Q2 | 558 | 624 | 0.94 | (0.85, 1.05) | 410 | 1.15 | (0.94, 1.40) | 3,116 | |||||
| Q1-low | 719 | 388 | 1.00 | (0.88, 1.13) | 491 | 1.08 | (0.89, 1.31) | 1,593 | |||||
| SCC | Q4-high | 57 | 1.00 | reference | 72 | 1.00 | reference | 26 | 1.00 | reference | 1,010 | 1.00 | Reference |
| Q3 | 105 | 1.06 | (0.76, 1.49) | 79 | 1.21 | (0.87, 1.71) | 85 | 1,285 | |||||
| Q2 | 166 | 1.12 | (0.83, 1.56) | 93 | 135 | 1,204 | |||||||
| Q1-low | 216 | 1.11 | (0.82, 1.52) | 46 | 1.35 | (0.91, 2.00) | 229 | 809 | |||||
| SCLC | Q4-high | 46 | 1.00 | reference | 37 | 1.00 | reference | 21 | 1.00 | reference | 730 | 1.00 | Reference |
| Q3 | 83 | 1.01 | (0.70, 1.49) | 40 | 1.12 | (0.69, 1.82) | 48 | 1.20 | (0.70, 2.14) | 938 | |||
| Q2 | 115 | 1.01 | (0.71, 1.47) | 40 | 1.32 | (0.82, 2.15) | 86 | 1.60 | (0.97, 2.75) | 959 | |||
| Q1-low | 162 | 1.06 | (0.75, 1.51) | 31 | 141 | 625 | |||||||
| LC+OSC | Q4-high | 52 | 1.00 | reference | 55 | 1.00 | reference | 18 | 1.00 | reference | 623 | 1.00 | Reference |
| Q3 | 88 | 0.97 | (0.67, 1.40) | 50 | 1.06 | (0.71, 1.60) | 41 | 1.11 | (0.62, 2.10) | 595 | |||
| Q2 | 108 | 0.82 | (0.58, 1.17) | 41 | 1.03 | (0.67, 1.59) | 59 | 1.27 | (0.73, 2.32) | 516 | |||
| Q1-low | 116 | 29 | 1.21 | (0.74, 1.97) | 91 | 1.62 | (0.96, 2.91) | 316 | |||||
| Unspecified | Q4-high | 53 | 1.00 | reference | 128 | 1.00 | reference | 41 | 1.00 | reference | 1,005 | 1.00 | Reference |
| Q3 | 115 | 1.21 | (0.86, 1.72) | 126 | 1.09 | (0.84, 1.41) | 84 | 1.07 | (0.72, 1.62) | 1,055 | |||
| Q2 | 139 | 1.02 | (0.74, 1.44) | 80 | 0.81 | (0.60, 1.09) | 117 | 1.13 | (0.78, 1.68) | 922 | |||
| Q1-low | 184 | 1.01 | (0.74, 1.41) | 77 | 1.28 | (0.95, 1.72) | 165 | 1.27 | (0.89, 1.86) | 563 | |||
1. Bold type indicates statistical significance
2. AAPI, Asian American/Pacific Islander; nSES, neighborhood socioeconomic status; IRR, incidence rate ratio; CI, confidence interval; SCC, squamous cell carcinoma; SCLC, small cell lung cancer; LC+OSC, large cell and other cell lung cancer
Lung cancer incidence rate ratios for all lung cancers and histologic cell-types by Hispanic ethnic enclave for Hispanic males and females, California 2008–2012.
| Male | Female | ||||||
|---|---|---|---|---|---|---|---|
| Ethnic enclave | Cases | IRR | (95% CI | Cases | IRR | (95% CI) | |
| Overall lung cancer | Q4-high | 1953 | 1.00 | reference | 1440 | 1.00 | reference |
| Q3 | 1257 | 1.02 | (0.95, 1.10) | 1141 | |||
| Q2 | 744 | 1.07 | (0.97, 1.17) | 805 | |||
| Q1-low | 452 | 503 | |||||
| Adenocarcinoma | Q4-high | 801 | 1.00 | reference | 767 | 1.00 | reference |
| Q3 | 569 | 600 | |||||
| Q2 | 330 | 446 | |||||
| Q1-low | 197 | 271 | |||||
| SCC | Q4-high | 430 | 1.00 | reference | 197 | 1.00 | reference |
| Q3 | 276 | 1.02 | (0.87, 1.19) | 174 | |||
| Q2 | 165 | 1.03 | (0.85, 1.24) | 110 | |||
| Q1-low | 111 | 1.20 | (0.96, 1.49) | 63 | |||
| SCLC | Q4-high | 237 | 1.00 | reference | 149 | 1.00 | reference |
| Q3 | 114 | 116 | 1.17 | (0.90, 1.50) | |||
| Q2 | 83 | 0.96 | (0.73, 1.25) | 89 | |||
| Q1-low | 38 | 0.73 | (0.49, 1.04) | 52 | |||
| LC+OSC | Q4-high | 165 | 1.00 | reference | 128 | 1.00 | reference |
| Q3 | 117 | 1.26 | (0.97, 1.63) | 117 | |||
| Q2 | 51 | 0.89 | (0.62, 1.24) | 68 | |||
| Q1-low | 41 | 1.42 | (0.97, 2.03) | 51 | |||
| Unspecified | Q4-high | 320 | 1.00 | reference | 199 | 1.00 | reference |
| Q3 | 181 | 0.88 | (0.72, 1.07) | 134 | 1.06 | (0.84, 1.34) | |
| Q2 | 115 | 1.01 | (0.8, 1.27) | 92 | 1.23 | (0.95, 1.59) | |
| Q1-low | 65 | 0.96 | (0.71, 1.27) | 66 | |||
1. Bold type indicates statistical significance
2. IRR, incidence rate ratio; CI, confidence interval; SCC, squamous cell carcinoma; SCLC, small cell lung cancer; LC+OSC, large cell and other cell lung cancer
Lung cancer incidence rate ratios for all lung cancers and histologic cell-types by Asian ethnic enclave for AAPI males and females, California 2008–2012.
| Male | Female | ||||||
|---|---|---|---|---|---|---|---|
| Ethnic enclave | Cases | IRR | (95% CI | Cases | IRR | (95% CI) | |
| Overall lung cancer | Q4-high | 3237 | 1.00 | reference | 2246 | 1.00 | reference |
| Q3 | 965 | 0.96 | (0.89, 1.03) | 737 | 0.99 | (0.91, 1.08) | |
| Q2 | 511 | 0.93 | (0.84, 1.02) | 454 | 1.08 | (0.97, 1.20) | |
| Q1-low | 202 | 0.93 | (0.80, 1.08) | 197 | 1.15 | (0.99, 1.33) | |
| Adenocarcinoma | Q4-high | 1714 | 1.00 | reference | 1667 | 1.00 | reference |
| Q3 | 505 | 0.93 | (0.84, 1.04) | 520 | 0.93 | (0.84, 1.02) | |
| Q2 | 263 | 0.91 | (0.79, 1.04) | 298 | 0.96 | (0.84, 1.09) | |
| Q1-low | 102 | 0.89 | (0.72, 1.09) | 125 | 0.98 | (0.81, 1.18) | |
| SCC | Q4-high | 591 | 1.00 | reference | 145 | 1.00 | reference |
| Q3 | 185 | 1.03 | (0.87, 1.22) | 73 | |||
| Q2 | 99 | 1.01 | (0.80, 1.25) | 44 | |||
| Q1-low | 45 | 1.13 | (0.80, 1.54) | 28 | |||
| SCLC | Q4-high | 278 | 1.00 | reference | 79 | 1.00 | reference |
| Q3 | 72 | 0.83 | (0.62, 1.08) | 31 | 1.21 | (0.76, 1.86) | |
| Q2 | 42 | 0.86 | (0.60, 1.20) | 20 | 1.32 | (0.76, 2.21) | |
| Q1-low | 20 | 0.99 | (0.58, 1.58) | 18 | |||
| Unspecified | Q4-high | 467 | 1.00 | reference | 257 | 1.00 | reference |
| Q3 | 154 | 1.04 | (0.86, 1.26) | 70 | 0.84 | (0.64, 1.11) | |
| Q2 | 82 | 1.00 | (0.77, 1.27) | 68 | |||
| Q1-low | 27 | 0.92 | (0.59, 1.36) | 16 | 0.80 | (0.45, 1.35) | |
1. Bold type indicates statistical significance
2. Results not provided for LC+OSC due to low numbers
3. AAPI, Asian American/Pacific Islander; IRR, incidence rate ratio; CI, confidence interval; SCC, squamous cell carcinoma; SCLC, small cell lung cancer; LC+OSC, large cell and other cell lung cancer
Lung cancer incidence rate ratios for all lung cancers and lung adenocarcinomas by joint nSES, ethnic enclave for Hispanic and AAPI males and females, California 2008–2012.
| Overall lung cancer | Low nSES, High enclave | 1896 | 1.00 | 1390 | 1.00 | ||
| Low nSES, Low enclave | 1188 | 1093 | |||||
| High nSES, High enclave | 57 | 1.03 | (0.77, 1.35) | 50 | 1.14 | (0.84, 1.51) | |
| High nSES, Low enclave | 1265 | 1.03 | (0.95, 1.11) | 1356 | |||
| Adenocarcinoma | Low nSES, High enclave | 784 | 1.00 | reference | 740 | 1.00 | reference |
| Low nSES, Low enclave | 522 | 537 | |||||
| High nSES, High enclave | 17 | 0.79 | (0.45, 1.27) | 27 | 1.14 | (0.74, 1.67) | |
| High nSES, Low enclave | 574 | 780 | |||||
| Overall lung cancer | Low nSES, High enclave | 1153 | 1.00 | 720 | 1.00 | ||
| Low nSES, Low enclave | 979 | 0.93 | (0.86, 1.02) | 729 | 1.05 | (0.94, 1.16) | |
| High nSES, High enclave | 122 | 1.10 | (0.91, 1.34) | 85 | 1.16 | (0.91, 1.46) | |
| High nSES, Low enclave | 2661 | 2100 | 0.98 | (0.89, 1.06) | |||
| Adenocarcinoma | Low nSES, High enclave | 575 | 1.00 | 524 | 1.00 | ||
| Low nSES, Low enclave | 459 | 488 | 0.96 | (0.84, 1.09) | |||
| High nSES, High enclave | 61 | 1.10 | (0.82, 1.44) | 60 | 1.10 | (0.83, 1.45) | |
| High nSES, Low enclave | 1489 | 1538 | 0.97 | (0.88, 1.08) | |||
1. Bold type indicates statistical significance.
2. Low nSES, quartiles 1–2; High SES, quartiles 3–4; High enclave, quartile 4; Low enclave, quartiles 1–3.
3. AAPI, Asian American/Pacific Islander; IRR, incidence rate ratio; CI, confidence interval.